Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Modulatory mechanism of the endogenous peptide catestatin on neuronal nicotinic acetylcholine receptors and exocytosis.
Herrero CJ
,
Alés E
,
Pintado AJ
,
López MG
,
García-Palomero E
,
Mahata SK
,
O'Connor DT
,
García AG
,
Montiel C
.
???displayArticle.abstract???
The catestatin fragment of chromogranin A is the first known endogenous compound able to inhibit catecholamine release elicited by the activation of neuronal nicotinic acetylcholine receptors (nAChRs) of different animal species and catecholaminergic cell types. However, how catestatin regulates the receptor activity, which subunit combination of the heteropentameric forms of receptor is better blocked by the peptide, or how it affects the different stages of the exocytotic process have not yet been evaluated. To address these questions, we have assayed the effects of catestatin: (first) on the inward currents elicited by ACh (I(ACh)) in voltage-clamped oocytes expressing different combinations of nAChR subunits; and (second) on the cytosolic Ca2+ concentration, [Ca2+]c, and quantal release of catecholamines simultaneously monitored in single adrenal chromaffin cells stimulated with ACh. Catestatin potently blocks all the subtypes of nAChRs studied. Furthermore, it inhibits the alpha3beta4 current in a reversible, noncompetitive, voltage-, and use-dependent manner, a behavior compatible with open-channel blockade. In fura-2-loaded single chromaffin cells, the peptide reduced the [Ca2+]c signal and the total release of catecholamines elicited by ACh; however, catestatin did not modify the kinetics or the last step of the exocytotic process. Our results suggest that catestatin might play an autocrine regulatory role in neuroendocrine secretion through its interaction with different native nAChR subtypes; the extent of receptor blockade by the peptide could be acutely regulated by the intensity and duration of the presynaptic stimulus.
Aardal,
The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels.
1992, Pubmed
Aardal,
The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels.
1992,
Pubmed
Albillos,
Opioid inhibition of Ca2+ channel subtypes in bovine chromaffin cells: selectivity of action and voltage-dependence.
1996,
Pubmed
Ales,
The sea anemone toxin Bc2 induces continuous or transient exocytosis, in the presence of sustained levels of high cytosolic Ca2+ in chromaffin cells.
2000,
Pubmed
Almers,
The Ca signal from fura-2 loaded mast cells depends strongly on the method of dye-loading.
1985,
Pubmed
Alvarez de Toledo,
Release of secretory products during transient vesicle fusion.
1993,
Pubmed
Blaschko,
Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation.
1967,
Pubmed
Boyd,
Desensitization of membrane-bound Torpedo acetylcholine receptor by amine noncompetitive antagonists and aliphatic alcohols: studies of [3H]acetylcholine binding and 22Na+ ion fluxes.
1984,
Pubmed
Campos-Caro,
Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: cloning, expression, and genomic organization of receptor subunits.
1997,
Pubmed
,
Xenbase
Chow,
Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells.
1992,
Pubmed
Criado,
Primary structure of an agonist binding subunit of the nicotinic acetylcholine receptor from bovine adrenal chromaffin cells.
1992,
Pubmed
Galzi,
Neuronal nicotinic receptors: molecular organization and regulations.
1995,
Pubmed
Gandía,
ATP modulation of calcium channels in chromaffin cells.
1993,
Pubmed
García-Guzmán,
alpha-Bungarotoxin-sensitive nicotinic receptors on bovine chromaffin cells: molecular cloning, functional expression and alternative splicing of the alpha 7 subunit.
1995,
Pubmed
,
Xenbase
Gil,
Dual effects of botulinum neurotoxin A on the secretory stages of chromaffin cells.
1998,
Pubmed
Gopalakrishnan,
Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
1996,
Pubmed
Goumon,
The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity.
1996,
Pubmed
Grynkiewicz,
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
1985,
Pubmed
Heidmann,
Fast kinetic studies on the interaction of a fluorescent agonist with the membrane-bound acetylcholine receptor from Torpedo marmorata.
1979,
Pubmed
Heidmann,
Fast kinetic studies on the allosteric interactions between acetylcholine receptor and local anesthetic binding sites.
1979,
Pubmed
Helle,
Chromogranin A: osmotically active fragments and their susceptibility to proteolysis during lysis of the bovine chromaffin granules.
1990,
Pubmed
Hernández-Guijo,
Separation of calcium channel current components in mouse chromaffin cells superfused with low- and high-barium solutions.
1998,
Pubmed
Herrero,
Differential blockade of rat alpha3beta4 and alpha7 neuronal nicotinic receptors by omega-conotoxin MVIIC, omega-conotoxin GVIA and diltiazem.
1999,
Pubmed
,
Xenbase
Kilpatrick,
Ion channels and membrane potential in stimulus-secretion coupling in adrenal medulla cells.
1981,
Pubmed
Kopell,
Osmotic pressures of solutions of ATP and catecholamines relating to storage in chromaffin granules.
1982,
Pubmed
Kumakura,
Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells.
1980,
Pubmed
Leszczyszyn,
Nicotinic receptor-mediated catecholamine secretion from individual chromaffin cells. Chemical evidence for exocytosis.
1990,
Pubmed
Léna,
Allosteric modulations of the nicotinic acetylcholine receptor.
1993,
Pubmed
López,
Unmasking the functions of the chromaffin cell alpha7 nicotinic receptor by using short pulses of acetylcholine and selective blockers.
1998,
Pubmed
,
Xenbase
Mahata,
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
1997,
Pubmed
Mahata,
Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance.
1999,
Pubmed
Mahata,
Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.
2000,
Pubmed
Miledi,
Chloride current induced by injection of calcium into Xenopus oocytes.
1984,
Pubmed
,
Xenbase
Miledi,
Properties of acetylcholine receptors translated by cat muscle mRNA in Xenopus oocytes.
1982,
Pubmed
,
Xenbase
Montiel,
Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors.
1997,
Pubmed
,
Xenbase
Papke,
The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Pintado,
The novel Na(+)/Ca(2+) exchange inhibitor KB-R7943 also blocks native and expressed neuronal nicotinic receptors.
2000,
Pubmed
,
Xenbase
Rahamimoff,
Pre- and postfusion regulation of transmitter release.
1997,
Pubmed
Schroeder,
Temporally resolved, independent stages of individual exocytotic secretion events.
1996,
Pubmed
Segura,
Automatic analysis for amperometrical recordings of exocytosis.
2000,
Pubmed
Sen,
Molecular mobilities and the lowered osmolality of the chromaffin granule aqueous phase.
1982,
Pubmed
Stafford,
The beta subunit of neuronal nicotinic acetylcholine receptors is a determinant of the affinity for substance P inhibition.
1994,
Pubmed
,
Xenbase
Strub,
Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules.
1996,
Pubmed
Séguéla,
Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium.
1993,
Pubmed
,
Xenbase
Tatemoto,
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
,
Pubmed
Taylor,
Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules.
2000,
Pubmed
Thomas,
A low affinity Ca2+ receptor controls the final steps in peptide secretion from pituitary melanotrophs.
1993,
Pubmed
Trifaró,
Morphological characteristics and stimulus-secretion coupling in bovine adcrenal chromaffin cell cultures.
1980,
Pubmed
Tsigelny,
Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity.
1998,
Pubmed
Wilson,
The acetylcholine receptor of the adrenal medulla.
1977,
Pubmed
Winkler,
The molecular function of adrenal chromaffin granules: established facts and unresolved topics.
1986,
Pubmed
Xu,
Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors.
1999,
Pubmed
Xu,
Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity.
1998,
Pubmed
Yu,
Functional contribution of the alpha7 subunit to multiple subtypes of nicotinic receptors in embryonic chick sympathetic neurones.
1998,
Pubmed
